RNS Number : 2993Q
Volex PLC
18 June 2020

Volex plc

("Volex" or the "Company") 

Investor Presentation

Volex plc (AIM: VLX), the global provider of complex assemblies for performance critical applications and power products, is pleased to announce Daren Morris and Nat Rothschild will provide a live presentation relating to its Full Year Results for the year ended 5 April 2020 via the Investor Meet Company platform on 23 June 2020 at 10.30am

The Company is committed to ensuring that there are appropriate communication structures for all elements of its shareholder base so that its strategy, business model and performance are clearly understood.


• The online presentation is open to all existing and potential shareholders.


• Questions can be submitted pre-event via your IMC dashboard or any time during the live presentation via the "Ask a Question" function. Although the Company may not be in a position to answer every question it receives, it will address the most prominent within the confines of information already disclosed to the market. Responses to the Q&A from the live presentation will be published at the earliest opportunity on the Investor Meet Company platform.


• Investor feedback can also be submitted directly to management post-event to ensure the Company can understand the views of all elements of its shareholder base.


Investors can sign up to Investor Meet Company for free and add to meet Volex plc via:




Investors who have already registered and added to meet the Company will be automatically invited.


For further information please contact:

Volex plc

+44 7909 995 887

Nat Rothschild, Executive Chairman

Daren Morris, Chief Financial Officer and Company Secretary


N+1 Singer - Nominated Adviser & Joint Broker

+44 20 7496 3000

Shaun Dobson

Iqra Amin


Whitman Howard - Joint Broker

+44 20 7659 1234

Hugh Rich

Nick Lovering


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.